Overview

A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus

Status:
Terminated
Trial end date:
2008-02-19
Target enrollment:
Participant gender:
Summary
To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Insulin
Insulin, Globin Zinc